Improvement of Radioimmunotherapy Using Pretargeting

During the past two decades, considerable research has been devoted to radionuclide therapy using radiolabeled monoclonal antibodies and receptor binding agents. Conventional radioimmunotherapy (RIT) is now an established and important tool in the treatment of hematologic malignancies such as Non-Ho...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Frampas, Eric, Rousseau, Caroline, Bodet-Milin, Caroline, Barbet, Jacques, Chatal, Jean-Francois, Kraeber-Bodéré, Françoise
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2013
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3687199/
https://ncbi.nlm.nih.gov/pubmed/23802097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2013.00159
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky